ÂÜÀòÂÒÂ×

Bo Huang, PhD, FASA, is an experienced statistician currently serving as the Executive Director and head of the Non-Malignant Hematology Statistics Group at Pfizer since January 2008, managing over 15 statisticians in support of a portfolio that includes seven drugs in clinical development for hemophilia and sickle cell disease. Prior roles at Pfizer included Senior Director and Head of Immuno-Oncology Statistics, where Bo Huang led statistical initiatives for various cancers and drug submissions. Additional contributions to the field include serving as Associate Editor for journals such as the New England Journal of Statistics in Data Science and involvement with the American Statistical Association as Industry Co-Chair and Program Chair for the Biopharmaceutical Section. Educational foundations include a Ph.D. in Statistics from the University of Wisconsin-Madison and a B.S. in Mathematical Statistics from Nankai University.